Skip to main content
FinSpry Logo
FinSpry
AQST logo
AQST
(NASDAQ)
Aquestive Therapeutics, Inc.
$4.13-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Aquestive Therapeutics (AQST) Stock Price & Financial Analysis

Aquestive Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$4.04 - $4.18
52-Week High$7.55
52-Week Low$2.12
Open$4.06
Volume901.24K
Average Volume (3M)901.24K
Market Cap503.72M
Shares Outstanding121.97M
Price to Sales (P/S)11.31
EV/EBITDA-7.02
Revenue (TTM)44.55M
Net Income (TTM)-83.78M
Free Cash Flow (TTM)-52.99M
EPS (TTM)$-0.69
Profit Margin-188.09%
Operating Margin-159.50%
50-Day MA$3.92
200-Day MA$4.80
52-Week Change44.41%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Aquestive Therapeutics

What is the current stock price for AQST?

As of the latest trading session, AQST stock trades at $4.13. The 52-week range is $2.12–$7.55, with a day range of $4.04–$4.17.

What is the P/E ratio for AQST?

The P/E ratio (Price-to-Earnings) for AQST is shown in the Key Statistics section. This valuation metric helps compare Aquestive Therapeutics, Inc. to industry peers.

Does AQST pay dividends?

Aquestive Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for AQST?

Based on 5 analysts, the consensus for AQST is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of AQST?

Aquestive Therapeutics's market capitalization is $503.7M, classifying it as a small-cap company. Aquestive Therapeutics operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.